The Bladder Cancer Company

About Us

Our Values

Our History

Bladder cancer challenge

Board of directors

Executive Leadership

Leadership

Our Company

Photocure Technology

Our products

Research support

Innovation & Products

News

Bladder Cancer and AI

Addressing Inequality

Our Perspective

Patient Registries And Real-World Evidence

Bladder cancer community support

Corporate social responsibility

ESG Report

Our Impact

Why Partner with Photocure

Our Partners

Partners

Photocure culture

Working at Photocure

Careers

Contact

Events & Presentations

Financials

Shareholder information

FAQs

Investors hub

Investors

Press & Media

Privacy Policy

Terms of use

cevira

<p class="spacer"><br></p>
<h1>Shareholders</h1>
<p class="spacer"><br></p>

thumbnail_ShareHolderInfo@2x.png

ESG report

Photocure ASA - Notice of the Annual General Meeting 5 May 2025

Medical congresses & events

Financial Investment & Stock

Photocure ASA: Annual Report 2024

Photocure ASA: Transactions made under share buyback program

Photocure ASA - Share option grant to Vice President and General Manager EMEA

Photocure appoints Jane Healy as Vice President and General Manager EMEA

Organisational Announcements

Clinical data presentations at the European Association of Urology (EAU) 2025 congress highlight the benefits of using Blue Light Cystoscopy in bladder cancer

Medical Information

Patient Registries

Real World Evidence

Photocure ASA: Initiation of a share buyback

New BRAVO Study Publication Reinforces Clinical Benefits of BLC in Reducing Risk of Bladder Cancer Recurrence

Photocure ASA: Results for the fourth quarter of 2024

News on Richard Wolf/Photocure Collaboration: Interim Flexible BLC solution available in countries where System blue and Richard Wolf reusable flexible cystoscopes are cleared

Product Announcements

Partnership News & Expansion

Bladder Cancer: Upstaging and risk mitigation with Blue Light Cystoscopy in NMIBC featured at ASCO GU 2025

Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2024 financial results

Photocure Partner Asieris awarded "Annual Star of Innovation" with Hexvix at the 5th Annual Lunjian Awards 2024

<p>We use cookies to provide the best possible experience for you. By closing this message you agree to our use of cookies. You can learn more about cookies on our <a href="https://photocure.com/privacy-policy" target="_blank" rel="noopener noreferrer" aria-label="privacy page (opens in a new tab)" title="Opens in a new tab">privacy page</a>.</p>

agree

Shareholders

Investor news